These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Factors related to screening of hepatitis C virus in general medicine]. Rotily M, Loubière S, Prudhomme J, Portal I, Tran A, Hofliger P, Valla D, Moatti JP. Gastroenterol Clin Biol; 2002 Mar; 26(3):261-9. PubMed ID: 11981471 [Abstract] [Full Text] [Related]
8. Management of hepatitis C among drug users attending general practice in Ireland: baseline data from the Dublin area hepatitis C in general practice initiative. Cullen W, Stanley J, Langton D, Kelly Y, Bury G. Eur J Gen Pract; 2007 Mar; 13(1):5-12. PubMed ID: 17366287 [Abstract] [Full Text] [Related]
9. Evolution over a 10 year period of the epidemiological profile of 1,726 newly diagnosed HCV patients in Belgium. Gérard C, Delwaide J, Vaira D, Bastens B, Servais B, Wain E, Bataille C, Daenen G, Belaïche J, GLEVHE. J Med Virol; 2005 Aug; 76(4):503-10. PubMed ID: 15977247 [Abstract] [Full Text] [Related]
10. Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia. Vicknasingam B, Narayanan S, Navaratnam V. Drug Alcohol Rev; 2009 Jul; 28(4):447-54. PubMed ID: 19594801 [Abstract] [Full Text] [Related]
12. Assessment and proposal of a new combination of screening criteria for hepatitis C in France. King LA, Le Strat Y, Meffre C, Delarocque-Astagneau E, Desenclos JC. Eur J Public Health; 2009 Oct; 19(5):527-33. PubMed ID: 19667051 [Abstract] [Full Text] [Related]
15. [Epidemiology of hepatitis C virus infection in 1,304 HCV positive patients: variations according to the origin of transmission and year of diagnosis]. Guyader D, Lefeuvre C, Jacquelinet S, Prat M, Baudouard Y, Turlin B, André P, Mendler MH, Sapey T, Boucher E, Moirand R, Messner M, Colimon R, Brissot P, Deugnier Y. Gastroenterol Clin Biol; 1998 Apr; 22(4):375-80. PubMed ID: 9762266 [Abstract] [Full Text] [Related]
16. Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factors. Loebstein R, Mahagna R, Maor Y, Kurnik D, Elbaz E, Halkin H, Olchovsky D, Ezra D, Almog S. Isr Med Assoc J; 2008 Nov; 10(11):775-8. PubMed ID: 19070285 [Abstract] [Full Text] [Related]
17. [Modalities of care in anti HCV positive patients identified in General Medicine in the Alpes-Maritimes district]. Ouzan D, Cavailler P, Hofliger P, Mamino C, Joly H, Tran A. Gastroenterol Clin Biol; 2003 Apr; 27(4):376-80. PubMed ID: 12759676 [Abstract] [Full Text] [Related]
18. Prevalence and risk factors of hepatitis C infection after cardiac surgery in childhood before and after blood donor screening. Vogt M, Mühlbauer F, Braun SL, Lang T, Busch R, Lange R, Frösner G, Hess J. Infection; 2004 Jun; 32(3):134-7. PubMed ID: 15188071 [Abstract] [Full Text] [Related]